PMC:7594251 / 122660-122924 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T100","span":{"begin":141,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma9601"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T39","span":{"begin":141,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A39","pred":"uberon_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T128","span":{"begin":141,"end":154},"obj":"Disease"},{"id":"T129","span":{"begin":148,"end":154},"obj":"Disease"}],"attributes":[{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A129","pred":"mondo_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T200","span":{"begin":102,"end":103},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T201","span":{"begin":141,"end":147},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T31260","span":{"begin":12,"end":23},"obj":"Chemical"},{"id":"T15844","span":{"begin":25,"end":27},"obj":"Chemical"},{"id":"T32244","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"T260","span":{"begin":76,"end":83},"obj":"Chemical"},{"id":"T49613","span":{"begin":125,"end":128},"obj":"Chemical"},{"id":"T64708","span":{"begin":178,"end":180},"obj":"Chemical"},{"id":"T69324","span":{"begin":196,"end":198},"obj":"Chemical"},{"id":"T79926","span":{"begin":217,"end":219},"obj":"Chemical"},{"id":"T18850","span":{"begin":227,"end":229},"obj":"Chemical"}],"attributes":[{"id":"A36335","pred":"chebi_id","subj":"T31260","obj":"http://purl.obolibrary.org/obo/CHEBI_31355"},{"id":"A50886","pred":"chebi_id","subj":"T15844","obj":"http://purl.obolibrary.org/obo/CHEBI_73890"},{"id":"A15364","pred":"chebi_id","subj":"T32244","obj":"http://purl.obolibrary.org/obo/CHEBI_15740"},{"id":"A84743","pred":"chebi_id","subj":"T32244","obj":"http://purl.obolibrary.org/obo/CHEBI_52343"},{"id":"A90164","pred":"chebi_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/CHEBI_30089"},{"id":"A17414","pred":"chebi_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/CHEBI_47622"},{"id":"A6834","pred":"chebi_id","subj":"T49613","obj":"http://purl.obolibrary.org/obo/CHEBI_3392"},{"id":"A34804","pred":"chebi_id","subj":"T64708","obj":"http://purl.obolibrary.org/obo/CHEBI_73890"},{"id":"A40128","pred":"chebi_id","subj":"T69324","obj":"http://purl.obolibrary.org/obo/CHEBI_49637"},{"id":"A64914","pred":"chebi_id","subj":"T79926","obj":"http://purl.obolibrary.org/obo/CHEBI_49637"},{"id":"A18234","pred":"chebi_id","subj":"T18850","obj":"http://purl.obolibrary.org/obo/CHEBI_49637"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2173","span":{"begin":156,"end":164},"obj":"Species"},{"id":"2240","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"2241","span":{"begin":12,"end":23},"obj":"Chemical"},{"id":"2242","span":{"begin":25,"end":27},"obj":"Chemical"},{"id":"2243","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"2244","span":{"begin":76,"end":83},"obj":"Chemical"},{"id":"2245","span":{"begin":196,"end":198},"obj":"Chemical"},{"id":"2246","span":{"begin":227,"end":229},"obj":"Chemical"},{"id":"2247","span":{"begin":238,"end":241},"obj":"Chemical"},{"id":"2354","span":{"begin":141,"end":154},"obj":"Disease"},{"id":"2376","span":{"begin":218,"end":226},"obj":"CellLine"}],"attributes":[{"id":"A2173","pred":"tao:has_database_id","subj":"2173","obj":"Tax:9606"},{"id":"A2240","pred":"tao:has_database_id","subj":"2240","obj":"MESH:C056507"},{"id":"A2241","pred":"tao:has_database_id","subj":"2241","obj":"MESH:D016190"},{"id":"A2243","pred":"tao:has_database_id","subj":"2243","obj":"MESH:C030544"},{"id":"A2244","pred":"tao:has_database_id","subj":"2244","obj":"MESH:D000085"},{"id":"A2247","pred":"tao:has_database_id","subj":"2247","obj":"MESH:C000615229"},{"id":"A2354","pred":"tao:has_database_id","subj":"2354","obj":"MESH:D001943"},{"id":"A2376","pred":"tao:has_database_id","subj":"2376","obj":"CVCL:Z499"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T25","span":{"begin":141,"end":154},"obj":"Phenotype"}],"attributes":[{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T845","span":{"begin":0,"end":194},"obj":"Sentence"},{"id":"T846","span":{"begin":196,"end":264},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Gemcitabine-carboplatin (GC) Identification of two biomarkers (formate and acetate) that can predict a positive response in MBC (metastatic breast cancer) patients treated with GC chemotherapy. 1H-NMR CPMG1H JRES1H,1H-COSY1H,1H-TOCSY1H,13C-HSQC1H,13C-HMBC [137]"}